Redmile Group LLC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:01 pm Sale |
2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,895,478 4.800% |
-302,013 (-9.45%) |
Filing |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,197,491 5.300% |
500,843 (+18.57%) |
Filing |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,696,648 4.500% |
-1,181,951 (-30.47%) |
Filing |
| 2023-02-14 4:28 pm Purchase |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,878,599 8.000% |
795,098 (+25.79%) |
Filing |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,083,501 8.600% |
-304,875 (-9.00%) |
Filing |
| 2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,388,376 9.600% |
-22,281 (-0.65%) |
Filing |
| 2020-06-09 4:18 pm Purchase |
2020-06-05 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,410,657 9.600% |
3,410,657 (New Position) |
Filing |